share_log

BTIG Initiates Coverage On Nurix Therapeutics With Buy Rating, Announces Price Target of $35

BTIG Initiates Coverage On Nurix Therapeutics With Buy Rating, Announces Price Target of $35

BTIG對Nurix Therapeutics啓動了覆蓋,給予買入評級,宣佈目標價格爲35美元。
Benzinga ·  2024/12/11 01:57  · 評級/大行評級

BTIG analyst Jeet Mukherjee initiates coverage on Nurix Therapeutics (NASDAQ:NRIX) with a Buy rating and announces Price Target of $35.

BTIG 分析師Jeet Mukherjee對Nurix Therapeutics(納斯達克:NRIX)進行覆蓋,給予買入評級,並宣佈目標價格爲35美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論